G Protein Null Mutation and Cardiac Receptor Signaling - Margaret Sowell

Abstract

Funding Agency

Agency: National Institute of Health (NIH)
Institute: National Heart, Lung, and Blood Institute (NHLBI)
Type: Clinical Investigator Award (CIA) (K08)
Project #: 7K08HL003411-03
Application #: 2707630
Study Section: Special Emphasis Panel (ZHL1-CSR-Y (F1))

Project Start: 1998-01-01
Project End: 2001-05-31
Budget Start: 1998-01-01
Budget End: 1998-05-31
Support Year: 3
Fiscal Year: 1997
Total Cost
Indirect Cost

Institution

Name: Indiana University-Purdue University at Indianapolis
Department: Internal Medicine/Medicine
Type: Schools of Medicine
DUNS #: 005436803

City: Indianapolis
State: IN
Country: United States
Zip Code: 46202

Related projects


NIH 2000 K08 HL	G Protein Null Mutation and Cardiac Receptor Signaling Sowell, Margaret O. / Indiana University-Purdue University at Indianapolis	$38,299
NIH 1999 K08 HL	G Protein Null Mutation and Cardiac Receptor Signaling Sowell, Margaret O. / Indiana University-Purdue University at Indianapolis
NIH 1998 K08 HL	G Protein Null Mutation and Cardiac Receptor Signaling Sowell, Margaret O. / Indiana University-Purdue University at Indianapolis
NIH 1997 K08 HL	G Protein Null Mutation and Cardiac Receptor Signaling Sowell, Margaret O. / Brigham and Women's Hospital
NIH 1997 K08 HL	G Protein Null Mutation and Cardiac Receptor Signaling Sowell, Margaret O. / Indiana University-Purdue University at Indianapolis
NIH 1996 K08 HL	G Protein Null Mutation and Cardiac Receptor Signaling Sowell, Margaret O. / Brigham and Women's Hospital

Publications

Ye, C; Sowell, M O; Vassilev, P M et al. (1999) Galpha(i2), Galpha(i3)and Galpha(o) are all required for normal muscarinic inhibition of the cardiac calcium channels in nodal/atrial-like cultured cardiocytes. J Mol Cell Cardiol 31:1771-81

Comments

Be the first to comment on Margaret Sowell's grant